Evidence map›Paper›PMID 38757320›Full record

ArticleCurrent pharmaceutical design2024

Protective Effects of the Aqueous Extract of

Sayyed Matin Ahmadi, Mohammad Yousofpour, Mohammad Kamalinejad, Arman Otroshi, Fereshteh Talebpour Amiri, Abbas Alipour, Mohammad Reza Zareinejad, Delavar Shahbazzadeh

Abstract read
PubMed Publisher
In one paragraph

Article in Current pharmaceutical design, 2024. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

8 authors.

Sayyed Matin AhmadiStudent Research Committee, Mazandaran University of Medical Sciences, Sari, Iran.
Mohammad YousofpourDepartment of Persian Medicine, Faculty of Medicine, Mazandaran University of Medical Sciences, Sari, Iran.
Mohammad KamalinejadDepartment of Pharmacognosy, School of Pharmacy, Shahid Beheshti University of Medical Sciences, Tehran, Iran.
Arman OtroshiIsfahan Clinical Toxicology Research Center, Isfahan University of Medical Sciences, Isfahan, Iran.
Fereshteh Talebpour AmiriDepartment of Anatomy, Molecular and Cell Biology Research Center, Mazandaran University of Medical Sciences, Sari, Iran.
Abbas AlipourCommunity Medicine Department, Medical Faculty, Mazandaran University of Medical Sciences, Sari, Iran.
Mohammad Reza ZareinejadVenom and Biotherapeutics Molecules Lab., Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Delavar ShahbazzadehVenom and Biotherapeutics Molecules Lab., Medical Biotechnology Department, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.ORCID 0000-0002-9066-8666

Funding

Mazandaran University of Medical Sciences [Student Grant No: 8639].
6 · The paper itself

Abstract

introduction

methodsTherefore, more efficient alternatives to treat patients deserve attention, and plants are extensively good candidates to be studied. This study aimed to assess the potential of the aqueous fraction of

resultsBy injecting 80 mg of the aqueous extract of

conclusionThus,

Indexed as

MalvaMice, Inbred BALB CPlant ExtractsScorpionsScorpion VenomsAnimalsAnimals, PoisonousMaleMiceScorpion StingsPlant ExtractsScorpion Venomsacute kidney injury.drug leadHemiscorpius lepturusMalva sylvestris (PANIRAK)Persian medicinescorpion envenomation

Identifiers

PMID38757320

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.